Atlas Trials

Product Transference Study of Testagen™ TDS®-Testosterone

Clinical trial NCT02733133 · NOT_YET_RECRUITING

Trial details

NCT number
NCT02733133
Sponsor
Transdermal Delivery Solutions Corp
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hypogonadotropism
Start date
2027-01-05
Primary completion
2027-10-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.